Drugs / Cultured Treg cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01795573 | Oct 2014 → Aug 2020 | graft versus host disease | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cultured Treg cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01795573 ↗ |
| Modality | Cell therapy | “donor regulatory T cells” NCT01795573 ↗ |